215 related articles for article (PubMed ID: 12464443)
1. Osteosarcoma as a second malignant neoplasm.
Hamre MR; Severson RK; Chuba P; Lucas DR; Thomas RL; Mott MP
Radiother Oncol; 2002 Dec; 65(3):153-7. PubMed ID: 12464443
[TBL] [Abstract][Full Text] [Related]
2. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
3. Descriptive epidemiology of malignant primary osteosarcoma using population-based registries, United States, 1999-2008.
Duong LM; Richardson LC
J Registry Manag; 2013; 40(2):59-64. PubMed ID: 24002129
[TBL] [Abstract][Full Text] [Related]
4. Patterns of bone sarcomas as a second malignancy in relation to radiotherapy in adulthood and histologic type.
Wu LC; Kleinerman RA; Curtis RE; Savage SA; Berrington de González A
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):1993-9. PubMed ID: 22964827
[TBL] [Abstract][Full Text] [Related]
5. The extremity localized classic osteosarcomas have better survival than the axial non-classics.
Lin L; Deng S; Zhang F; Liang Y; Huang Z
World J Surg Oncol; 2018 Feb; 16(1):39. PubMed ID: 29471883
[TBL] [Abstract][Full Text] [Related]
6. Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma.
Lee JS; DuBois SG; Boscardin WJ; Wustrack RL; Goldsby RE
Cancer; 2014 Dec; 120(24):3987-93. PubMed ID: 25116228
[TBL] [Abstract][Full Text] [Related]
7. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.
Mirabello L; Troisi RJ; Savage SA
Cancer; 2009 Apr; 115(7):1531-43. PubMed ID: 19197972
[TBL] [Abstract][Full Text] [Related]
8. Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood.
Le Vu B; de Vathaire F; Shamsaldin A; Hawkins MM; Grimaud E; Hardiman C; Diallo I; Vassal G; Bessa E; Campbell S; Panis X; Daly-Schveitzer N; Lagrange JL; Zucker JM; Eschwège F; Chavaudra J; Lemerle J
Int J Cancer; 1998 Jul; 77(3):370-7. PubMed ID: 9663598
[TBL] [Abstract][Full Text] [Related]
9. Combined modality treatment for osteosarcoma occurring as a second malignant disease. Cooperative German-Austrian-Swiss Osteosarcoma Study Group.
Bielack SS; Kempf-Bielack B; Heise U; Schwenzer D; Winkler K
J Clin Oncol; 1999 Apr; 17(4):1164. PubMed ID: 10561175
[TBL] [Abstract][Full Text] [Related]
10. Adverse impact of regional lymph node involvement in osteosarcoma.
Thampi S; Matthay KK; Goldsby R; DuBois SG
Eur J Cancer; 2013 Nov; 49(16):3471-6. PubMed ID: 23867123
[TBL] [Abstract][Full Text] [Related]
11. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
12. Incidence and grading of cranio-facial osteosarcomas.
van den Berg H; Merks JH
Int J Oral Maxillofac Surg; 2014 Jan; 43(1):7-12. PubMed ID: 24035127
[TBL] [Abstract][Full Text] [Related]
13. Incidence Trends in the Diagnosis of Giant Cell Tumor of Bone in Sweden Since 1958.
Rockberg J; Bach BA; Amelio J; Hernandez RK; Sobocki P; Engellau J; Bauer HC; Liede A
J Bone Joint Surg Am; 2015 Nov; 97(21):1756-66. PubMed ID: 26537163
[TBL] [Abstract][Full Text] [Related]
14. Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: National Cancer Data Base Report.
Damron TA; Ward WG; Stewart A
Clin Orthop Relat Res; 2007 Jun; 459():40-7. PubMed ID: 17414166
[TBL] [Abstract][Full Text] [Related]
15. Survival analysis of patients with metastatic osteosarcoma: a Surveillance, Epidemiology, and End Results population-based study.
Song K; Song J; Lin K; Chen F; Ma X; Jiang J; Li F
Int Orthop; 2019 Aug; 43(8):1983-1991. PubMed ID: 31127366
[TBL] [Abstract][Full Text] [Related]
16. Derivation and validation of risk groups in patients with osteosarcoma utilizing regression tree analysis.
Ilcisin LA; Ma C; Janeway KA; DuBois SG; Shulman DS
Pediatr Blood Cancer; 2021 Mar; 68(3):e28834. PubMed ID: 33258278
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors, disparity, and equity variables impacting prognosis in bone sarcomas of the hand: SEER database review.
Jawad MU; Bayne CO; Farhan S; Haffner MR; Carr-Ascher J; Alvarez E; Thorpe SW; Randall RL
J Surg Oncol; 2021 Dec; 124(8):1515-1522. PubMed ID: 34432316
[TBL] [Abstract][Full Text] [Related]
18. Survival outcomes of pediatric osteosarcoma and Ewing's sarcoma: a comparison of surgery type within the SEER database, 1988-2007.
Schrager J; Patzer RE; Mink PJ; Ward KC; Goodman M
J Registry Manag; 2011; 38(3):153-61. PubMed ID: 22223058
[TBL] [Abstract][Full Text] [Related]
19. Statistics of bone sarcoma in Japan: Report from the Bone and Soft Tissue Tumor Registry in Japan.
Ogura K; Higashi T; Kawai A
J Orthop Sci; 2017 Jan; 22(1):133-143. PubMed ID: 27847134
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting the incident juvenile bone tumors in an Austrian case-control study.
Frentzel-Beyme R; Becher H; Salzer-Kuntschik M; Kotz R; Salzer M
Cancer Detect Prev; 2004; 28(3):159-69. PubMed ID: 15225895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
